Introduction
Clarithromycin, a novel 14-membered macrolide, has demonstrated clinical efficacy against Mycobacterium avium in patients with acquired immune deficiency syndrome and is approved for such use. [1] [2] [3] [4] [5] Mycobacteria are acid-fast organisms which have an unusually thick and lipophilic cell wall. [6] [7] [8] The mycobacterial cell wall is an effective permeability barrier, playing a major role in intrinsic resistance to some antibiotics. [9] [10] [11] [12] Hydrophilic molecules such as -lactams may gain access via cell wall porins. 13 However, little is known about the penetration of hydrophobic molecules such as macrolides into mycobacteria. The antibacterial effect of clarithromycin and its 14-hydroxy metabolite, in common with that of established macrolides, is attributed to reversible binding to the 50S ribosomal subunit within the bacterial cell, which inhibits translocation of aminoacyl transfer-RNA and subsequent
Molecular basis of clarithromycin activity against Mycobacterium avium
and Mycobacterium smegmatis Clarithromycin, the 6-O-methyl derivative of erythromycin, is approved for treatment of Mycobacterium avium infections and for prophylaxis in patients at risk. Since clarithromycin is more active against mycobacteria than the parent compound, erythromycin, we evaluated the interaction of erythromycin and clarithromycin with cells and ribosomes isolated from M. avium and Mycobacterium smegmatis. The MIC of clarithromycin was 32 and 64 times lower than that of erythromycin for M. smegmatis and M. avium, respectively. The cellular uptake rate for clarithromycin was two-to five-fold faster than for erythromycin, and cellassociated clarithromycin reached a plateau two-fold higher than that of erythromycin after 3 h. Energy was not required for uptake. Fractionation of cell-associated clarithromycin yielded 12% in the walls, 21% bound to ribosomes, with the remainder being lost during work-up. In addition, three-to six-fold more clarithromycin was associated with the isolated cell integument compared with erythromycin. The K d for clarithromycin binding to ribosomes was 2.9-and 3.5-fold tighter for M. smegmatis and M. avium, respectively, than for erythromycin, due mainly to a slower off-rate. The log partition coefficients of the non-ionized form (log P u ) for clarithromycin and erythromycin were 3.24 and 2.92, respectively. Thus clarithromycin is more hydrophobic than erythromycin. This would favour more rapid diffusion within and across hydrophobic regions of the cell integument, since once a solute saturates a membrane the net flux across the membrane must equal the net flux within the membrane as dictated by diffusion. We conclude that the lower MIC of clarithromycin for M. avium and M. smegmatis is due to a combination of increased cellular uptake, the major factor, possibly through a peripheral hydrophobic layer, and increased binding affinity to ribosomes.
protein synthesis. 14, 15 The lower MIC of clarithromycin, 6-O-methyl erythromycin, compared with the parent compound erythromycin might be the result of faster entrance into cells, increased binding affinity to ribosomes, or a combination of these factors.
In this study we have investigated the mechanism of the increased anti-mycobacterial activity of clarithromycin compared with the parent compound, erythromycin, for both M. avium and Mycobacterium smegmatis. Our data provide the first detailed kinetic analysis of macrolide binding to mycobacterial ribosomes. They show that the lower MIC of clarithromycin is attributable in part to its increased hydrophobicity, and thus the ability to interact with and transverse the mycobacterial membrane, as well as to its increased affinity for ribosome binding.
Materials and methods

Chemicals
Radiolabelled macrolides, [N-methyl- 14 C] clarithromycin, 28 mCi/mmol (1.04 GBq/mmol) or [N-methyl- 14 C] erythromycin, 50 mCi/mmol (1.85 GBq/mmol), and unlabelled macrolides were prepared at Abbott Laboratories. Microbial growth media were purchased from Difco (Detroit, MI, USA). Silicone oils (Dow Corning 550, 556) were purchased from Accumetric, Inc. (Elizabethtown, KY, USA). All other reagents and chemicals were purchased from Sigma Chemical Co., unless otherwise noted.
Organisms and growth conditions
M. smegmatis MC 2 155 was grown at 37°C in Middlebrook 7H9 broth (Difco, Detroit, MI, USA) supplemented with 0.2% (v/v) glycerol and 5% (v/v) oleic acid-albumindextrose complex (OADC; Difco, Detroit, MI, USA). 16 A clinical isolate of M. avium (MAV-1) from a patient was also examined. This strain was grown at 37°C in Middlebrook 7H9 broth supplemented with 0.2% (v/v) glycerol and 10% (v/v) OADC.
Susceptibility testing
MIC values were determined by the agar macrodilution method. Mueller-Hinton agar (pH 7.4) supplemented with 5% (v/v) OADC for M. smegmatis, or 10% for M. avium, and containing serial two-fold dilutions of each antibiotic tested, was poured into quadrant petri dishes. The inoculum was prepared from 2 day cultures of M. smegmatis or 7 day cultures of smooth transparent colonies of M. avium in 7H9 broth supplemented with 0.2% (v/v) glycerol and 10% OADC, and adjusted to 1 mg/mL (wet weight), corresponding to an average of 10 9 cfu/mL. Fifty microlitres from each dilution were plated on to one quadrant. Each assay was performed in duplicate, and plates were incubated at 37°C for 3 days (M. smegmatis) or 7 days (M. avium). The MIC was defined as the lowest concentration of drug inhibiting more than 99% of the bacterial population grown on drug-free medium used as growth control. 17 
Macrolide uptake and association with whole cells and isolated cell walls
Organisms were grown at 37°C and harvested (A 420 nm ϭ C] erythromycin. Triplicate samples (100 L) were removed from the incubations at various times and cells were separated from the medium by centrifugation through silicone oil (specific gravity ϭ 1.02) as described previously. 18 The background of cellassociated macrolide was determined using cells labelled at 4°C for 0 to 180 min and separated from medium as described above. This background was subtracted from the cell-associated macrolide results at 37°C. Initial rates of macrolide uptake (in pmol/min per A 600 nm units of cells) were estimated based on the earliest time points taken. Means and standard deviations (S.D.) from triplicate assays were obtained. Results were also expressed as cellassociated macrolide after 180 min in pmol/A 600 units of cells. Cells were preincubated for 15 min with 10 mM sodium azide, 10 mM sodium fluoride, 10 mM sodium arsenate, or 0.1 mM carbonyl cyanide m-chlorophenylhydrazone at 37°C prior to incubating with radiolabelled macrolide for 20 min, in order to test the effects of metabolic inhibitors on macrolide uptake. Association of macrolides with isolated cell walls (prepared as described below) was monitored similarly using the same method.
The dissociation of macrolide from whole cells was examined as follows. Cells were incubated for 40 min with labelled macrolide (2 mg/L [ 14 C] clarithromycin) as described above, pelleted by centrifugation, and resuspended in fresh medium containing 20 mg/L unlabelled clarithromycin. Resuspended cells were incubated at 37°C with cell sampling done at 10, 20, 30, and 60 min after resuspension. The cellular location of macrolides in whole cells was determined as follows. M. smegmatis was incubated for 1 h with 2 mg/L of labelled erythromycin or clarithromycin, as described above for uptake experiments. Cells were washed twice in 5 mL of buffer A (10 mM Tris-HCl, 4 mM MgCl 2 , 10 mM NH 4 Cl, 100 mM KCl, pH 7.2), resuspended in 3.5 mL of buffer A, and lysed by three passes through the French pressure cell at 16,000 lb/in 2 . Membranes were removed by centrifugation at 30,000g for 30 min and the amount of membrane-associated radioactive macrolide was determined. The ribosome-macrolide complex in the S30 supernatant was trapped on nitrocellulose filters (see below) for determination of the amount of macrolide bound to ribosomes.
Preparation of ribosomes and macrolide binding studies
Harvested cells were washed twice in buffer A, suspended in the same buffer A, and lysed by either two passes through a French pressure cell at 16,000 lb/in 2 (M. smegmatis), or by sonication (M. avium) at 0°C for 30 min using 30 s bursts (Soniprep 150 Sonicator, 32 kHz). The lysate was incubated on ice for 15 min after addition of DNase (RNase free; Boehrinnger, Mannheim, Germany) at a concentration of 5 units/mL. Samples were centrifuged at 5,000g for 5 min to remove whole cells. Ribosomes were isolated by differential centrifugation (30,000g for 30 min to remove cell walls, which were saved for study), followed by centrifugation of the supernatant (100,000g for 60 min to pellet ribosomes). The pelleted ribosomes were resuspended in buffer A and stored at Ϫ80°C in small aliquots. Walls were suspended in buffer A at 0.5 A 420 nm units/mL and stored at Ϫ80°C.
Macrolide binding to ribosomes was conducted in buffer A at 25°C, and the drug-ribosome complex (in duplicate) trapped on 0.45 M pore-size nitrocellulose filters (Millipore) as described. 19, 20 The rate of the forward reaction (formation of the macrolide-ribosome complex) was calculated using the formula
where B 0 ϭ free drug and A 0 ϭ free ribsomes at time t ϭ 0; x ϭ drug-ribosome complex at time t; and k 1 ϭ the forward rate constant expressed in M Ϫ1 min Ϫ1 . The reverse rate constant was calculated using the equation y ϭ A 0 e Ϫkt -where A 0 ϭ the amount of ribosome-macrolide complex at time t ϭ 0; y ϭ the amount at time t; and k ϭ the rate constant for decay (k Ϫ1 ) -using the GraFit program version 3.0 (Erithacus Software, Ltd, Stains, UK). The half-life for the process was log e 2/k. The dissociation constant (K d ) was calculated using the formula, K d ϭ k Ϫ1/k1 , and is expressed in M.
Comparative binding of labelled macrolides was determined by competition with unlabelled macrolide. 20 Data were analysed using the equation ] clarithromycin. After chilling to 4°C on ice, the sample was layered on to a 15 to 30% linear sucrose gradient and centrifuged at ca. 180,000g for 5.0 h using a SW41 rotor in a Beckman L2-65B ultracentrifuge at 4°C. Tubes were fractionated from the bottom with a Hoeffer fractionator and 0.3 mL samples collected at the rate of 1.0 mL/min. Tris buffer (0.7 mL) was added to each fraction, and A 260 readings were recorded. The fractions were then added to scintillation vials containing 10 mL Insta-gel (Packard; Dowmero Grove, FL, USA) and their radioactivity was determined.
Determination of partition coefficients
The partition coefficients for the non-ionized forms of the macrolides were calculated from known K a , pK a , octanol-water partitioning data at various pH values using the formula
Results
Susceptibility testing
The MICs of clarithromycin, azithromycin, and erythromycin for M. smegmatis strain MC 2 -155 were 2, 8, and 64 mg/L respectively. The MIC values against the susceptible M. avium strain (MAV-1) were 1 mg/L for clarithromycin, and 32 mg/L for azithromycin and erythromycin.
Macrolide uptake
The time course of the interaction of macrolides with M. smegmatis is shown in Figure 1(a) and Table I . The initial uptake rates of clarithromycin and erythromycin for M. smegmatis strain MC 2 -155 were 0.51 Ϯ 0.016 and 0.11 Ϯ 0.008 pmol/min per A 600 units of cells, respectively. Cellassociated clarithromycin (minus background at 4°C) reached 15.6 Ϯ 1.2 pmol per A 600 unit (Figure 1(a) ) after 180 min. In contrast, cell-associated erythromycin reached only 6.3 Ϯ 0.4 pmol per A 600 unit. As shown in Table I , the uptake of clarithromycin in M. smegmatis remained unmodified when the experiments were conducted after incubation with metabolic inhibitors. Thus energy is not required for macrolide uptake, and passive diffusion through the cell integument will dictate the rate of uptake. Finally, the half-life for loss of cell-associated clarithromycin was about 15 min, demonstrating that cell association was reversible. Results of experiments with isolated cell walls showed that the association of clarithromycin was two-to three-fold higher than that of erythromycin, as was observed for whole cells (see below).
The time course of the interaction of macrolides with M. avium is shown in Figure 1 
Macrolide binding to ribosomes
Clarithromycin binding was specific for the 50S ribosomal subunit of M. avium (Figure 2) (Figure 4) , and the reverse rate constant (k Ϫ1 ) was 0.021 min Ϫ1 (half-life for dissociation ϭ 33 min), yielding a dissociation constant (K d ) value of 1.01 ϭ 10
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M. Clarithromycin and 14-hydroxyclarithromycin bound, respectively, 2.9-fold and 7.2-fold tighter than erythromycin to M. smegmatis ribosomes, as determined by a competition experiment ( Figure 5 ). The forward rate constant (k 1 ) for association of clarithromycin was 2.54 ϫ 10 7 M Ϫ1 min Ϫ1 , and the reverse rate constant (k Ϫ1 ) was 0.0089 min Ϫ1 with a dissociation constant (K d ) value of 3.50 ϫ 10 Ϫ10 M (Table II) . The forward rate constant for 14-hydroxyclarithromycin was significantly faster, and combined with the dissociation constant gave a K d of 1.40 ϫ 10 Ϫ10 M (Table II) .
Fractionation of cell-associated macrolide
We attempted to determine the association of macrolide with different cellular fractions after incubation with pmol/unit A 600 nm pmol/unit A 660 nm labelled clarithromycin, followed by washing and subsequent cell lysis. Using M. smegmatis, 12% and 21% of total cell-associated macrolide were found associated with recovered cell walls and ribosomes, respectively. In separate experiments, 15 to 17 pmol of clarithromycin bound to 6.6 ϫ 10 Ϫ3 A 420 nm units of isolated cell walls, compared to 5 to 6 pmol of erythromycin, clearly demonstrating the higher association of clarithromycin with the mycobacterial cell wall. These values translated to 11 pmol per A 600 unit and 4 pmol per A 600 unit for clarithromycin and erythromycin, respectively, of the original cells from which the cell walls were prepared, and were close to the values determined for whole cells (see Figure 1 ). In addition, the time taken to saturate cell walls (5 min) was much faster than the time taken to saturate cells.
Hydrophobicity of non-ionized macrolides
The measured P i (ionized) and P u (non-ionized) of clarithromycin were 0.43 and 1721, respectively; therefore, log P i ϭ Ϫ0.37 and log P u ϭ 3.24. The partition coefficients of erythromycin were log P i ϭ 0.89 and log P u ϭ 2.92, as reported previously. 18 These data show that the P u form of clarithromycin is more hydrophobic than the P u form of erythromycin, and thus should traverse the hydrophobic membrane environment more quickly.
Discussion
The differences in mycobacterial susceptibility to clarithromycin and erythromycin, particularly in M. avium and M. smegmatis, are striking. They are most likely caused by differences in membrane penetration and/or target binding affinity. The structural difference between erythromycin and clarithromycin is at a C-6 position on the macrolide ring: -OH for erythromycin and -OCH 3 for clarithromycin. As expected, the log partition coefficient of the non-ionized form of clarithromycin was greater than that for erythromycin. Since the cell wall barrier is a major cause of intrinsic resistance in mycobacteria, any marked improvement in drug penetration should lead to an increase in susceptibility. Likewise, an increase in binding affinity to the ribosomal target could lead to increased potency. Data presented in this report indicate that both parameters are involved in the increased potency of clarithromycin against M. avium and M. smegmatis.
Clarithromycin was taken up by whole cells at a faster rate and to a greater extent than was erythromycin ( Figure  1 ). Since the non-ionized form of clarithromycin (log P u ϭ 3.24) was more hydrophobic than non-ionized erythromycin (log P u ϭ 2.92), drug partitioning into the cell integument and diffusion through specific lipophilic layers None ( Ribosomes were incubated with labelled macrolide and layered on to a 15 to 30% linear sucrose gradient and centrifuged at ca. 180,000g for 5.0 h using a SW41 rotor in a Beckman L2-65B ultracentrifuge (4°C). Ribosomes were detected in the collected fractions at A 260 nm (ࠗ), then subjected to liquid scintillation counting for labelled macrolide (□). Identical results were obtained for M. smegmatis (data not shown).
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likely favour the more rapid entry and subsequent increased potency of clarithromycin over erythromycin. Among fluoroquinolones, alkyl substitution, which makes the compound more hydrophobic and less active towards most bacteria, increased the activity against M. avium.
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Even a small, hydrophilic agent like isoniazid could be made more effective against M. avium by the addition of hydrophobic substituents. 23 Increased hydrophobicity in itself does not guarantee antimycobacterial activity; a survey of 64 antibiotics tested against M. avium did not reveal a correlation between hydrophobicity and activity. 24 However, the most potent compounds were highly hydrophobic, partitioned favourably into lipids, and were specifically bound or associated with amphipathic lipids in the cell wall. 6 Further studies on the interaction of macrolides with the mycobacterial wall are in progress, and should provide valuable information for use in modulating the potency of macrolides against the mycobacteria.
Binding affinities of erythromycin, clarithromycin, and 14-hydroxyclarithromycin were within an order of magnitude of each other for ribosomes isolated from M. avium and M. smegmatis. However, significant differences were observed. In particular, compared with erythromycin, 14-hydroxyclarithromycin, with a faster on-rate, bound seven-fold tighter to M. smegmatis ribosomes, while clarithromycin, with a slower off-rate bound about threefold tighter. Likewise for M. avium clarithromycin with a slower off-rate, bound almost four-fold tighter than erythromycin. We have previously shown that the k Ϫ1 value of azithromycin was similar to that of erythromycin with ribosomes from Gram-positive organisms, while it was smaller (i.e. slower off-rate) with ribosomes from Gram-negative ribosomes. 18 In contrast, the k Ϫ1 of azithromycin was 11-fold larger (i.e. 11-fold faster offrate) than that of clarithromycin when measured with M. avium ribosomes (data not shown). Erythromycin binding to ribosomes from both species was similar, and overall there was less than a 10-fold difference in the binding of the different macrolides to ribosomes. Thus, differences in ribosome binding affinities do not appear to account entirely for the 32-to 64-fold differences in the MICs of clarithromycin and erythromycin, for both M. avium and M. smegmatis.
The increased rate of uptake is likely to be the more important factor defining the potency of macrolides on bacteria. Analysis (R. Goldman and J. Capobianco, unpublished data) with Haemophilus influenzae, Escherichia coli and Bacillus subtilis indicates that the rate of uptake, rather than ribosome binding kinetics, determines the MIC of macrolides with k 1 values of 10 6 M Ϫ1 min Ϫ1 or faster and K d of 1 ϫ 10 Ϫ7 M or better for interaction with ribosomes. A global analysis of our data with mycobacteria indicates that the rate and magnitude of macrolide association with cells is far in excess of the number and rate of synthesis of ribosomes, and the rate of growth (volume expansion). The velocity of passive diffusion across the mycobacterial integument is given by v ϭ PA (C out Ϫ C in ), where v ϭ net flux in mol/s; P ϭ permeability coefficient in cm/s; A ϭ cross-sectional area (cm 2 ); and C is drug concentration in M. P is related to K, the partition coefficient between the aqueous and membrane layers, and D m , the diffusion coefficient within the membrane phases wherein P ϭ KD m /x; x is the membrane thickness. As the non-ionized form of clarithromycin is more hydrophobic than erythromycin, this would favour more rapid diffusion within and across hydrophobic regions of the cell integument, since once a solute saturates a membrane the net flux across the membrane must equal the net flux within the membrane as dictated by diffusion. Our analysis suggests that the mycobacterial membrane represents a reservoir for macrolide which is far larger than the amount of macrolide bound to intracellular ribosomes. The fact that macrolides associate with isolated membrane fragments much faster than with intact cells is explained by the access of macrolide to the membrane area exposed laterally by fragmentation occurring during cell disruption (see Figure 6) . A final conclusion is that a central area of maximum macrolide accumulation is bounded on both sides by regions that are more restrictive of macrolide diffusion and accumulation: this appears to be the only way to explain the slower uptake in whole cells, and the need for excess cell-associated macrolide at the MIC value compared with the number of cellular ribosomes. This model predicts that equivalent amounts of macrolide would associate with cells of mycobacterial strains that are macrolide resistant because of a lack of binding of macrolides to ribosomes. 25, 26 Recent experimental data have revealed that this is indeed the case (unpublished observations). Access to the membrane is faster in fragmented membranes due to the exposure of lateral surfaces of the integument interior. Rate-limiting layers bind a central layer of greatest macrolide load. Once gaining access to the cytoplasm, macrolides bind to 50S ribosomal subunits and inhibit protein synthesis. The P and D m of clarithromycin are greater than those of erythromycin, hence increased flux across the membrane, and faster access to ribosomes at an equivalent macrolide concentration. This translates to a lower MIC value (see text for details).
